Instead of being cold, the Xintiandi Home Community Service Center was unusually warm in winter. Big Vision came here with a new generation of fully automated artificial intelligence OCT BV1000 to provide intimate fundus screening services to the elderly in the community. This is the third consecutive year that Chen Xinjian, a member of the Jiangsu Provincial Committee of the Chinese People’s Political Consultative Conference and chairman of Suzhou Big Vision.
The BV 1000 used in this public health screening is a fully automatic artificial intelligence OCT with independent intellectual property rights, which is a combination of software and hardware of Big Vision. An old man said that he had been to the hospital for several OCT examinations, but this is the fastest and most convenient one, which is really high-tech.
As China enters an aging society, the base of patients with various age-related eye diseases is huge, with about 30 million patients with diabetic retinopathy, 20 million patients with glaucoma, 10 million patients with age-related macular degeneration, and more than 100 million patients with various types of fundus diseases diagnosed, there is a huge demand for ophthalmic disease screening in the grassroots community, but the current OCT devices on the market are expensive and complicated to operate. However, the current OCT devices in the market are expensive and complicated to operate, and there is no one model that is particularly suitable for the screening market. Big Vision’s fully automated AI OCT combined with AI ophthalmic disease aid diagnosis system can provide a complete system solution for mass screening, which really fills this gap and has a broad market prospect.
No comments yet.